IGF-1 LR3 contains a 13-amino-acid N-terminal extension and a glutamic acid substitution at position 3, reducing binding affinity for IGF-binding proteins (IGFBPs) by approximately 100-fold compared to endogenous IGF-1
Click the "Print / Save PDF" button at the top of this article or press Ctrl+P (Windows) / Cmd+P (Mac) and select "Save as PDF." The page uses a print-optimized stylesheet that removes navigation and sidebars, formats all tables for clean A4 output, and preserves table borders
His love and dedication to the Dragons and the game for over 30 years is unmatched.
p-GSK-3, hosphor glycogen synthase kinase 3
We use expedited carriers to ensure your peptides arrive quickly and reliably nationwide
View Canadian testing status & COAs Suggested Research Applications KLOW is frequently explored in laboratory research models involving: Multi-peptide interaction studies across combined signaling pathways Extracellular matrix behavior, collagen-related signaling, and structural support systems Cellular communication and coordination between peptide-regulated processes Tissue response models, including environmental stress and recovery pathways Inflammatory signaling and peptide-mediated modulation in controlled environments Regeneration-associated pathways involving complex peptide stacks Comparative studies with formulations such as GLOW and individual peptide isolates (For laboratory research use only